Date  |
|
| Sep 18, 2020 |
CEL-SCI Awarded European Patent for LEAPS Vaccine in Treatment of Rheumatoid Arthritis |
| Sep 15, 2020 |
CEL-SCI Corporation Issues Letter to Shareholders |
| Sep 11, 2020 |
CEL-SCI Corporation to Present at H.C. Wainwright 22nd Annual Global Investment Conference |
| Aug 31, 2020 |
CEL-SCI Corporation to Present at The LD 500 Virtual Conference |
| Aug 11, 2020 |
CEL-SCI Corporation Reports Third Quarter Fiscal 2020 Financial Results |
| Jul 24, 2020 |
CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment |
| Jun 30, 2020 |
CEL-SCI Corporation Receives $10 Million Through Warrant Exercises |
| Jun 24, 2020 |
CEL-SCI to Present at H.C. Wainwright Virtual Fireside Chat Series |
| May 11, 2020 |
CEL-SCI Corporation Reports Second Quarter Fiscal 2020 Financial Results |
| May 4, 2020 |
CEL-SCI’s Pivotal Phase 3 Study Has Reached the Required Number of Events to Evaluate Data for Multikine in Treatment of Head and Neck Cancer |